MannKind Closes The Deal With The Global Diabetes Powerhouse Sanofi

Some investors have been feeling anxious regarding whether MannKind Corporation (NASDAQ: MNKD) would finalize the deal with the French Pharmaceutical Powerhouse Sanofi (NYSE: SNY).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.